Dyadic International (DYAI) Current Leases (2023 - 2026)
Dyadic International (DYAI) posted Current Leases of $19998.0 for Q1 2026, down 42.24% sequentially from $34621.0 in Q4 2025, and down 64.22% YoY from $55895.0 in Q1 2025.
Dyadic International (DYAI) Current Leases (2023 - 2026) Analysis & Trends
Dyadic International has reported Current Leases for 4 years, with the latest figure at $19998.0 in Q1 2026.
- Quarterly Current Leases fell 64.22% year-over-year to $19998.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19998.0 (down 64.22% YoY) and the FY2025 annual result came in at $34621.0, down 36.18% from the prior year.
- Current Leases eased to $19998.0 in Q1 2026 per DYAI's latest filing, from $34621.0 in the prior quarter.
- Over five years, Current Leases peaked at $57577.0 in Q2 2025 and troughed at $19998.0 in Q1 2026.
- A 4-year average of $47275.2 and a median of $49551.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2026: Current Leases climbed 14.76% in 2024, then plunged 64.22% in 2026.
- Over 4 years, Current Leases stood at $48059.0 in 2023, then rose by 12.88% to $54249.0 in 2024, then tumbled by 36.18% to $34621.0 in 2025, then sank by 42.24% to $19998.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $19998.0, $34621.0, and $48927.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Dyadic International | 20.18 Mn | 20.18 Mn | - | 19,998.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,998.00 |
| Dec 31, 2025 | 34,621.00 |
| Sep 30, 2025 | 48,927.00 |
| Jun 30, 2025 | 57,577.00 |
| Mar 31, 2025 | 55,895.00 |
| Dec 31, 2024 | 54,249.00 |
| Sep 30, 2024 | 53,476.00 |
| Jun 30, 2024 | 51,075.00 |
| Mar 31, 2024 | 49,551.00 |
| Dec 31, 2023 | 48,059.00 |
| Sep 30, 2023 | 46,599.00 |